{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:43:59Z","timestamp":1788853439700,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40272-025-00708-3","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T23:55:21Z","timestamp":1751759721000},"page":"619-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effective Sirolimus Use in Prenatal and Postnatal Management of Symptomatic Extensive Congenital Capillary-Lymphatic-Venous Malformations (CLVMs): A Report of Two Cases"],"prefix":"10.1007","volume":"27","author":[{"given":"Anna","family":"Klosowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Styczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata A.","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Gluszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Adamski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wartecka-Zielinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Matwiejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Rybak-Krzyszkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Dziechcinska-Poletek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Sinacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Wyrzykowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Taczanowska-Niemczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gabrych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Kielpinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia K.","family":"Mazur-Ejankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Domzalska-Popadiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena Emilia","family":"Grzybowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz G.","family":"Wydra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Gorecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninela","family":"Irga-Jaworska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-2686","authenticated-orcid":false,"given":"Ewa","family":"Bien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,6]]},"reference":[{"key":"708_CR1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","volume":"166","author":"VL Luks","year":"2015","unstructured":"Luks VL, Kamitaki N, Vivero MP, et al. Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015;166:1048-1054.e5. https:\/\/doi.org\/10.1016\/j.jpeds.2014.12.069.","journal-title":"J Pediatr"},{"key":"708_CR2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","volume":"164","author":"KM Keppler-Noreuil","year":"2014","unstructured":"Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet Pt A. 2014;164:1713\u201333. https:\/\/doi.org\/10.1002\/ajmg.a.36552.","journal-title":"Am J Med Genet Pt A"},{"key":"708_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ajmg.a.36836","volume":"167","author":"KM Keppler-Noreuil","year":"2015","unstructured":"Keppler-Noreuil KM, Rios JJ, Parker VER, et al. PIK3CA -related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J of Med Genet Pt A. 2015;167:287\u201395. https:\/\/doi.org\/10.1002\/ajmg.a.36836.","journal-title":"Am J of Med Genet Pt A"},{"key":"708_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/exd.12826","volume":"25","author":"H Vahidnezhad","year":"2016","unstructured":"Vahidnezhad H, Youssefian L, Uitto J. Klippel\u2013Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS). Exp Dermatol. 2016;25:17\u20139. https:\/\/doi.org\/10.1111\/exd.12826.","journal-title":"Exp Dermatol"},{"key":"708_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/cge.14027","volume":"101","author":"S Douzgou","year":"2022","unstructured":"Douzgou S, Rawson M, Baselga E, et al. A standard of care for individuals with PIK3CA-related disorders: an international expert consensus statement. Clin Genet. 2022;101:32\u201347. https:\/\/doi.org\/10.1111\/cge.14027.","journal-title":"Clin Genet"},{"key":"708_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10456-020-09722-0","volume":"23","author":"TD Le Cras","year":"2020","unstructured":"Le Cras TD, Goines J, Lakes N, et al. Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation. Angiogenesis. 2020;23:425\u201342. https:\/\/doi.org\/10.1007\/s10456-020-09722-0.","journal-title":"Angiogenesis"},{"key":"708_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/cge.13543","volume":"96","author":"S Frisk","year":"2019","unstructured":"Frisk S, Taylan F, Blaszczyk I, et al. Early activating somatic PIK3CA mutations promote ectopic muscle development and upper limb overgrowth. Clin Genet. 2019;96:118\u201325. https:\/\/doi.org\/10.1111\/cge.13543.","journal-title":"Clin Genet"},{"key":"708_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/children11050567","volume":"11","author":"FCM Bouwman","year":"2024","unstructured":"Bouwman FCM, Verhoeven BH, Klein WM, et al. Congenital vascular malformations in children: from historical perspective to a multidisciplinary approach in the modern era\u2014a comprehensive review. Children. 2024;11:567. https:\/\/doi.org\/10.3390\/children11050567.","journal-title":"Children"},{"key":"708_CR9","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.3390\/biomedicines10102422","volume":"10","author":"G Sibrecht","year":"2022","unstructured":"Sibrecht G, Wr\u00f3blewska-Seniuk K, Kornacki J, et al. Multispecialty approach to a very large congenital head and neck cystic lymphatic malformation in an infant born by SARS-CoV-2 positive mother\u2014a case report. Biomedicines. 2022;10:2422. https:\/\/doi.org\/10.3390\/biomedicines10102422.","journal-title":"Biomedicines"},{"key":"708_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30215","volume":"70","author":"ER Engel","year":"2023","unstructured":"Engel ER, Hammill A, Adams D, et al. Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: impact on symptomatology, quality of life, and radiographic response. Pediatr Blood Cancer. 2023;70: e30215. https:\/\/doi.org\/10.1002\/pbc.30215.","journal-title":"Pediatr Blood Cancer"},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/pd.6321","volume":"43","author":"S Agarwal","year":"2023","unstructured":"Agarwal S, Mehollin-Ray A, Sutton VR, et al. Prenatal diagnosis of vascular anomalies. Prenat Diagn. 2023;43:318\u201327. https:\/\/doi.org\/10.1002\/pd.6321.","journal-title":"Prenat Diagn"},{"key":"708_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jpedsurg.2014.11.024","volume":"50","author":"P Laje","year":"2015","unstructured":"Laje P, Peranteau WH, Hedrick HL, et al. Ex utero intrapartum treatment (EXIT) in the management of cervical lymphatic malformation. J Pediatr Surg. 2015;50:311\u20134. https:\/\/doi.org\/10.1016\/j.jpedsurg.2014.11.024.","journal-title":"J Pediatr Surg"},{"key":"708_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pd.5428","volume":"39","author":"AA Shamshirsaz","year":"2019","unstructured":"Shamshirsaz AA, Stewart KA, Erfani H, et al. Cervical lymphatic malformations: prenatal characteristics and ex utero intrapartum treatment. Prenat Diagn. 2019;39:287\u201392. https:\/\/doi.org\/10.1002\/pd.5428.","journal-title":"Prenat Diagn"},{"key":"708_CR14","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1111\/jog.15436","volume":"48","author":"J Muromoto","year":"2022","unstructured":"Muromoto J, Sugibayashi R, Ozawa K, et al. A fetus with large mediastinal cystic lymphatic malformation managed with prenatal serial thoracocentesis and postnatal sclerotherapy. J Obstet Gynaecol Res. 2022;48:3308\u201313. https:\/\/doi.org\/10.1111\/jog.15436.","journal-title":"J Obstet Gynaecol Res"},{"key":"708_CR15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/pd.5925","volume":"41","author":"J Livingston","year":"2021","unstructured":"Livingston J, Alrowaily N, John P, et al. Fetal therapy using rapamycin for a rapidly enlarging, obstructive, cervical lymphatic malformation: a case report. Prenat Diagn. 2021;41:884\u20137. https:\/\/doi.org\/10.1002\/pd.5925.","journal-title":"Prenat Diagn"},{"key":"708_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s44161-023-00280-4","volume":"2","author":"E Seront","year":"2023","unstructured":"Seront E, Biard JM, Van Damme A, et al. A case report of sirolimus use in early fetal management of lymphatic malformation. Nat Cardiovasc Res. 2023;2:595\u20139. https:\/\/doi.org\/10.1038\/s44161-023-00280-4.","journal-title":"Nat Cardiovasc Res"},{"key":"708_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jpedsurg.2022.10.028","volume":"58","author":"A Muntean","year":"2023","unstructured":"Muntean A, Cazacu R, Ade-Ajayi N, et al. The long-term outcome following thoraco-amniotic shunting for congenital lung malformations. J Pediatr Surg. 2023;58:213\u20137. https:\/\/doi.org\/10.1016\/j.jpedsurg.2022.10.028.","journal-title":"J Pediatr Surg"},{"key":"708_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/pd.6492","volume":"44","author":"S Qaderi","year":"2024","unstructured":"Qaderi S, Javinani A, Blumenfeld YJ, et al. Mammalian target of rapamycin inhibitors: a new-possible approach for in-utero medication therapy. Prenat Diagn. 2024;44:88\u201398. https:\/\/doi.org\/10.1002\/pd.6492.","journal-title":"Prenat Diagn"},{"key":"708_CR19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3257","volume":"137","author":"DM Adams","year":"2016","unstructured":"Adams DM, Trenor CC, Hammill AM, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016;137: e20153257. https:\/\/doi.org\/10.1542\/peds.2015-3257.","journal-title":"Pediatrics"},{"key":"708_CR20","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pbc.23124","volume":"57","author":"AM Hammill","year":"2011","unstructured":"Hammill AM, Wentzel M, Gupta A, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57:1018\u201324. https:\/\/doi.org\/10.1002\/pbc.23124.","journal-title":"Pediatr Blood Cancer"},{"key":"708_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/JOVA.0000000000000065","volume":"4","author":"P Triana","year":"2023","unstructured":"Triana P, D\u00edez-Sebasti\u00e1n J, Rodriguez-Laguna L, et al. Sirolimus early treatment in vascular anomalies leads to a better response. J Vasc Anom. 2023;4: e065. https:\/\/doi.org\/10.1097\/JOVA.0000000000000065.","journal-title":"J Vasc Anom"},{"key":"708_CR22","unstructured":"U.S. Food & Drug Administration. RAPAMUNE (sirolimus) Prescribing Information 2022. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=021110. Accessed 23 June 2025."},{"key":"708_CR23","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.transproceed.2008.06.015","volume":"40","author":"S-H Chu","year":"2008","unstructured":"Chu S-H, Liu K-L, Chiang Y-J, et al. Sirolimus used during pregnancy in a living related renal transplant recipient: a case report. Transplant Proc. 2008;40:2446\u20138. https:\/\/doi.org\/10.1016\/j.transproceed.2008.06.015.","journal-title":"Transplant Proc"},{"key":"708_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.22551\/2021.31.0802.10180","volume":"8","author":"S Tshering","year":"2021","unstructured":"Tshering S, Dorji N, Sonam Y. Maternal sirolimus therapy and fetal growth restriction. Arch Clin Cases. 2021;8:19\u201324. https:\/\/doi.org\/10.22551\/2021.31.0802.10180.","journal-title":"Arch Clin Cases"},{"key":"708_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26470","volume":"64","author":"T Mizuno","year":"2017","unstructured":"Mizuno T, Fukuda T, Emoto C, et al. Developmental pharmacokinetics of sirolimus: implications for precision dosing in neonates and infants with complicated vascular anomalies. Pediatr Blood Cancer. 2017;64: e26470. https:\/\/doi.org\/10.1002\/pbc.26470.","journal-title":"Pediatr Blood Cancer"},{"key":"708_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/pediatric15010020","volume":"15","author":"J Will","year":"2023","unstructured":"Will J, Siedentopf N, Schmid O, et al. Successful prenatal treatment of cardiac rhabdomyoma in a fetus with tuberous sclerosis. Pediatr Rep. 2023;15:245\u201353. https:\/\/doi.org\/10.3390\/pediatric15010020.","journal-title":"Pediatr Rep"},{"key":"708_CR27","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1007\/s12325-021-01758-y","volume":"38","author":"VEM Harbers","year":"2021","unstructured":"Harbers VEM, Rongen GAPJM, van der Vleuten CJM, et al. Patients with congenital low-flow vascular malformation treated with low dose sirolimus. Adv Ther. 2021;38:3465\u201382. https:\/\/doi.org\/10.1007\/s12325-021-01758-y.","journal-title":"Adv Ther"},{"key":"708_CR28","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1111\/bcp.15202","volume":"88","author":"VEM Harbers","year":"2022","unstructured":"Harbers VEM, van der Salm N, Pegge SAH, et al. Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach\u2013Merritt phenomenon in young infants. Br J Clin Pharmacol. 2022;88:2769\u201381. https:\/\/doi.org\/10.1111\/bcp.15202.","journal-title":"Br J Clin Pharmacol"},{"key":"708_CR29","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","volume":"21","author":"VER Parker","year":"2019","unstructured":"Parker VER, Keppler-Noreuil KM, Faivre L, et al. Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum. Genet Med. 2019;21:1189\u201398. https:\/\/doi.org\/10.1038\/s41436-018-0297-9.","journal-title":"Genet Med"},{"key":"708_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29603","volume":"69","author":"KA Shimano","year":"2022","unstructured":"Shimano KA, Eng W, Adams DM. How we approach the use of sirolimus and new agents: medical therapy to treat vascular anomalies. Pediatr Blood Cancer. 2022;69: e29603. https:\/\/doi.org\/10.1002\/pbc.29603.","journal-title":"Pediatr Blood Cancer"},{"key":"708_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.5468\/ogs.2019.62.4.280","volume":"62","author":"H Park","year":"2019","unstructured":"Park H, Chang CS, Choi S-J, et al. Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis. Obstet Gynecol Sci. 2019;62:280. https:\/\/doi.org\/10.5468\/ogs.2019.62.4.280.","journal-title":"Obstet Gynecol Sci"},{"key":"708_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/pd.5613","volume":"40","author":"ID Pluym","year":"2020","unstructured":"Pluym ID, Sklansky M, Wu JY, et al. Fetal cardiac rhabdomyomas treated with maternal sirolimus. Prenat Diagn. 2020;40:358\u201364. https:\/\/doi.org\/10.1002\/pd.5613.","journal-title":"Prenat Diagn"},{"key":"708_CR33","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1056\/NEJMc1800352","volume":"378","author":"BT Barnes","year":"2018","unstructured":"Barnes BT, Procaccini D, Crino J, et al. Maternal sirolimus therapy for fetal cardiac rhabdomyomas. N Engl J Med. 2018;378:1844\u20135. https:\/\/doi.org\/10.1056\/NEJMc1800352.","journal-title":"N Engl J Med"},{"key":"708_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.733823","volume":"9","author":"N Chaphekar","year":"2021","unstructured":"Chaphekar N, Dodeja P, Shaik IH, et al. Maternal-fetal pharmacology of drugs: a review of current status of the application of physiologically based pharmacokinetic models. Front Pediatr. 2021;9: 733823. https:\/\/doi.org\/10.3389\/fped.2021.733823.","journal-title":"Front Pediatr"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-025-00708-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-025-00708-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-025-00708-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T14:11:09Z","timestamp":1756390269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-025-00708-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,6]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1007\/s40272-025-00708-3","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,6]]},"assertion":[{"value":"5 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was received for conducting this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Anna Klosowska, Malgorzata Styczewska, Malgorzata A. Krawczyk, Lena Gluszkiewicz, Przemyslaw Adamski, Katarzyna Wartecka-Zielinska, Lukasz Matwiejczyk, Magda Rybak-Krzyszkowska, Daria Dziechcinska-Poletek, Anna Jankowska, Katarzyna Sinacka, Dariusz Wyrzykowski, Anna Taczanowska-Niemczuk, Anna Gabrych, Paulina Kielpinska, Natalia K. Mazur-Ejankowska, Iwona Domzalska-Popadiuk, Magdalena Emilia Grzybowska, Prof. Dariusz G. Wydra, Wojciech Gorecki, Ninela Irga-Jaworska, and Ewa Bien declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No public data other than those presented in the article are available. Additional information on the presented patients is available on request from the corresponding author.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Bioethics Committee for Scientific Research of the Medical Universityof Gdansk, Poland.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Both pregnant women signed an informed consent before the off-label sirolimus treatment. Additional separate informed consents were obtained from the mothers to publish the case reports, including photographs of their children.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Conceptualization\u2014Anna Klosowska, Malgorzata Styczewska, Malgorzata A. Krawczyk, and Ewa Bien; methodology\u2014Anna Klosowska, Malgorzata Styczewska, Malgorzata A. Krawczyk, and Ewa Bien; formal analysis and investigation\u2014Anna Klosowska, Malgorzata Styczewska, Malgorzata A. Krawczyk, Ewa Bien, Lena Gluszkiewicz, Przemyslaw Adamski, Katarzyna Wartecka-Zielinska, Lukasz Matwiejczyk, Magda Rybak-Krzyszkowska, Daria Dziechcinska-Poletek, Anna Jankowska, Katarzyna Sinacka, Dariusz Wyrzykowski, Anna Taczanowska-Niemczuk, Anna Gabrych, Paulina Kielpinska, Natalia K. Mazur-Ejankowska, and Magdalena E. Grzybowska; writing\u2014original draft preparation\u2014Anna Klosowska, Malgorzata Styczewska, Malgorzata A. Krawczyk, and Ewa Bien; writing\u2014review and editing\u2014Lena Gluszkiewicz, Przemyslaw Adamski, Katarzyna Wartecka-Zielinska, Lukasz Matwiejczyk, Magda Rybak-Krzyszkowska, Daria Dziechcinska-Poletek, Anna Jankowska, Katarzyna Sinacka, Dariusz Wyrzykowski, Anna Taczanowska-Niemczuk, Anna Gabrych, Paulina Kielpinska, Natalia K. Mazur-Ejankowska, Magdalena E. Grzybowska, Ninela Irga-Jaworska, Iwona Domzalska-Popadiuk, Wojciech Gorecki, and Dariusz G. Wydra; resources\u2014Przemyslaw Adamski, Katarzyna Wartecka-Zielinska, Lukasz Matwiejczyk, Magda Rybak-Krzyszkowska, Daria Dziechcinska-Poletek, Anna Jankowska, Katarzyna Sinacka, Dariusz Wyrzykowski, Anna Taczanowska-Niemczuk, Magdalena E. Grzybowska, Ewa Bien, Ninela Irga-Jaworska, Iwona Domzalska-Popadiuk, Wojciech Gorecki, and Dariusz G. Wydra; supervision\u2014Ewa Bien, Ninela Irga-Jaworska, Iwona Domzalska-Popadiuk, Wojciech Gorecki, and Dariusz G. Wydra.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}